Solve M.E. is pleased to welcome Dr. Sadie Whittaker back to the organization as Chief Scientific Officer, a role in which she will continue to guide our scientific strategy and research priorities.
Sadie previously served as Solve M.E.’s Chief Scientific Officer (2018-2021). She led the organization’s research strategy, launched the You + ME® Registry and symptom tracking app, and built strong partnerships with researchers, clinicians, and patient communities to advance understanding of ME/CFS.
Sadie has broad scientific and clinical expertise and has held several C-suite positions within biotech start-ups, where she has guided therapies from early development through pivotal trials and regulatory milestones.
In this role, Sadie will provide strategic oversight of our research portfolio, advise on emerging scientific opportunities, and support key partnerships that advance our mission.
Sadie remarked, “I’m thrilled to be back at Solve M.E. as Chief Scientific Officer! I’m looking forward to reconnecting with the ME/CFS community to push the science forward, strengthen partnerships, and uncover new opportunities where Solve can make an impact. Together with this community, I am determined to translate rigorous, patient-centered science into meaningful change for people living with ME/CFS and related diseases.”
This appointment reflects Solve M.E.’s commitment to patient-centered science and thoughtful stewardship of resources—ensuring continuity while accelerating progress where it matters most.
We are grateful to continue working with Sadie as we push forward urgently needed research and understanding.
